In response to RFA MD-08-001, the NCMHD Endowment Program for Increasing Research and Institutional Resources Capacity in Section 736 Health Professions Schools, Charles Drew University of Medicine and Science (CDU) seeks endowment funding to build capacity and research infrastructure that will facilitate the University's ongoing health disparity research activities. Through its NCMHD-supported and endowed Medical Sciences Institute (MSI), CDU seeks to creatively design a research environment where a strong, diverse scientific community can unite in addressing solutions to close the gap between the burden of illness and premature mortality experienced more commonly by racial and ethnic minorities and other medically underserved populations, as compared with the nation as a whole. The proposed endowment portfolio will bolster current MSI-endowed funds currently managed through a collaboration with the University of California, Los Angeles (UCLA) Endowment Foundation, providing an established underpinning of effective and sophisticated portfolio management consistent with the highest level of standards in the nation. The endowment portfolio will be allocated among a number of asset classes that may include domestic equity, domestic fixed income, international equity, international fixed income, private equity, venture capital and cash to ensure the proper level of diversification and the fiscal solvency necessary for creating a self-sustaining research infrastructure at CDU. Following are the Specific Aims:
Specific Aim 1 : Enhance the institutional capacity and infrastructure at CDU, with an emphasis on the College of Science and Health (including the new nursing program) and the College of Medicine (including the planned four-year medical school), to conduct and/or participate as informed team members in translational approaches (team science) on research focused on reducing health disparities;
Specific Aim 2 : Create a Center for Community Engagement, including support for a new community faculty track, to create a novel learning environment for CDU health professional students who are committed to serving and transforming the health of underserved communities;
Specific Aim 3 : Implement a scholarly activity support office to promote innovation and increase academic productivity in the areas of (1) intellectual property and technology transfer and (2) grants, invited presentations, and peer-reviewed publications that have high potential to impact the health disparities gap;
and Specific Aim 4 : Effectively manage the endowment portfolio at a level consistent with the highest fiduciary standards in the nation.

Public Health Relevance

In response to RFA MD-08-001, the NCMHD Endowment Program for Increasing Research and Institutional Resources Capacity in Section 736 Health Professions Schools, Charles Drew University of Medicine and Science (CDU) seeks endowment funding to build capacity and research infrastructure that will facilitate the University's ongoing health disparity research activities. Through its NCMHD-supported and endowed Medical Sciences Institute (MSI), CDU seeks to creatively design a research environment where a strong, diverse scientific community can unite in addressing solutions to close the gap between the burden of illness and premature mortality experienced more commonly by racial and ethnic minorities and other medically underserved populations, as compared with the nation as a whole.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Research and Institutional Resources Health Disparities Endowment Grants -Capacity Building (S21)
Project #
5S21MD000103-09
Application #
7692326
Study Section
Special Emphasis Panel (ZMD1-LW (09))
Program Officer
Stinson, Nathaniel
Project Start
2001-09-26
Project End
2011-08-31
Budget Start
2009-09-16
Budget End
2010-08-31
Support Year
9
Fiscal Year
2009
Total Cost
$5,000,000
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Elsaid, Ahmed F; Shaheen, Magda; Ghoneum, Mamdooh (2018) Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double-blind, placebo-controlled clinical trial. Exp Ther Med 15:2313-2320
Chung, Seyung S; Dutta, Pranabananda; Austin, David et al. (2018) Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9:32943-32957
Singh, Rajan; Pervin, Shehla; Lee, Se-Jin et al. (2018) Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases. Diabetes Metab Syndr Obes 11:65-84
Jenders, Robert A; Adlassnig, Klaus-Peter; Fehre, Karsten et al. (2018) Evolution of the Arden Syntax: Key Technical Issues from the Standards Development Organization Perspective. Artif Intell Med 92:10-14
Hanuscin, Chris; Zahmatkesh, Golara; Shirazi, Anaheed et al. (2018) Socio-Demographic and Mental Health Profile of Admitted Cases of Self-Inflicted Harm in the US Population. Int J Environ Res Public Health 15:
Wu, Y; Vadgama, J V (2017) Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech 3:
Kermah, Dulcie; Shaheen, Magda; Pan, Deyu et al. (2017) Association between secondhand smoke and obesity and glucose abnormalities: data from the National Health and Nutrition Examination Survey (NHANES 1999-2010). BMJ Open Diabetes Res Care 5:e000324
Yen, Eric Y; Shaheen, Magda; Woo, Jennifer M P et al. (2017) 46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study. Ann Intern Med 167:777-785
Pervin, Shehla; Singh, Vineeta; Tucker, Alexandria et al. (2017) Modulation of transforming growth factor-?/follistatin signaling and white adipose browning: therapeutic implications for obesity related disorders. Horm Mol Biol Clin Investig 31:
Wang, Piwen; Solorzano, Walter; Diaz, Tanya et al. (2017) Arctigenin inhibits prostate tumor cell growth in vitro and in vivo. Clin Nutr Exp 13:1-11

Showing the most recent 10 out of 85 publications